Literature DB >> 24190720

The "true prevalence" of mental illness in a new england state.

D L Phillips1.   

Abstract

Utilizing the 22-Item Mental Health Scale developed by the staff of the Midtown Manhattan Project, the mental health status of a sample of 600 New Hampshire residents is examined. The findings suggest that more than one-quarter of the respondents in the sample are psychosocially impaired to varying degrees. The results also indicate that approximately 15 per cent of the respondents had previously sought help for problems of a psychiatric nature. Also considered is the distribution of mental illness in different State regions and the relationship of mental illness to several demographic and sociocultural factors.

Entities:  

Year:  1966        PMID: 24190720     DOI: 10.1007/BF01420320

Source DB:  PubMed          Journal:  Community Ment Health J        ISSN: 0010-3853


  2 in total

1.  A twenty-two item screening score of psychiatric symptoms indicating impairment.

Authors:  T S LANGNER
Journal:  J Health Hum Behav       Date:  1962

2.  Uses and limitations of the California Health Survey for studying the epidemiology of chronic disease.

Authors:  L BRESLOW
Journal:  Am J Public Health Nations Health       Date:  1957-02
  2 in total
  4 in total

1.  Anomia, socioeconomic status, and mental disturbance.

Authors:  A M Reinhardt; R M Gray
Journal:  Community Ment Health J       Date:  1972-05

2.  Anxiety: its role in the history of psychiatric epidemiology.

Authors:  J M Murphy; A H Leighton
Journal:  Psychol Med       Date:  2008-10-22       Impact factor: 7.723

3.  The relationship between health-related stressful life events and anxiety: an analysis of a Florida metropolitan community.

Authors:  S A Dzegede; S W Pike; J R Hackworth
Journal:  Community Ment Health J       Date:  1981

4.  The relative effectiveness of two models for scoring the mid-town psychological disorder index.

Authors:  P N Haese; R L Meile
Journal:  Community Ment Health J       Date:  1967-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.